Search results
Fulgent Announces Second Drug in Development and New Prenatal Genetic Test
Los Angeles Business Journal· 19 hours agoEl Monte-based genetic testing and analysis company Fulgent Genetics Inc., which rode the Covid...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoNEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Anavex Life Sciences Corp. (NASDAQ: AVXL) on behalf of long-term stockholders
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoSAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) shares. Investors, who purchased Anavex Life
New gene delivery vehicle shows promise for human brain gene therapy
Science Daily· 5 days agoGene therapy could potentially treat a range of severe genetic brain disorders, which currently have no cures and few treatment options. The enormous challenge of getting therapies past this ...
Taysha Gene Therapies Inc (TSHA) Q1 2024 Earnings Call Transcrip
Guru Focus· 6 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. The company successfully enrolled the first patient in the high-dose cohort of their REVEAL ...
In a GOP stronghold, two Democrats seek chance to take on Wittman
Richmond Times-Dispatch· 3 days agoTwo Democrats — the former legal director of the ACLU of Virginia, and New Kent County’s former...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $7.00 Consensus PT from Analysts
ETF DAILY NEWS· 1 day agoTaysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received an average rating of “Buy” from the nine research firms that are currently covering the company, Marketbeat reports.
Leerink Partnrs Research Analysts Increase Earnings Estimates for ACADIA Pharmaceuticals Inc....
ETF DAILY NEWS· 6 days agoACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Research analysts at Leerink Partnrs upped their FY2026 earnings per share (EPS) estimates for shares of ACADIA Pharmaceuticals in a ...
Neurogene (NASDAQ:NGNE) Price Target Cut to $51.00
ETF DAILY NEWS· 6 days agoNeurogene (NASDAQ:NGNE – Get Free Report) had its target price decreased by equities researchers at HC Wainwright from $55.00 to $51.00 in a note issued to investors on Monday, Benzinga reports ...
Short Interest in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Grows By 7.8%
ETF DAILY NEWS· 4 days agoACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 12,030,000 shares ...
